Skip to main content
. 2017 Dec 14;36(5):438–445. doi: 10.1200/JCO.2017.74.5497

Fig 1.

Fig 1.

Relationship between patient age and papillary thyroid cancer (PTC)–specific mortality in all patients, patients with BRAF V600E mutation, and patients with wild-type BRAF. (A) Mortality rates and (B) accumulated mortality rates by patient age in all patients with PTC. (C) Mortality rates and (D) accumulated mortality rates of patients with conventional PTC.